Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice

Journal of Lipid Research

Volumn 51, Issue 12, 2010, Pages 3414-3424

  Volynets, Valentina ^a   Spruss, Astrid ^a   Kanuri, Giridhar ^a   Wagnerberger, Sabine ^a   Bischoff, Stephan C ^a   Bergheim, Ina ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Endotoxin; Nonalcoholic fatty liver disease; Occludin; Tumor necrosis factor

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DRINKING WATER; ENDOTOXIN; FARNESOID X RECEPTOR; FAS ANTIGEN; FRUCTOSE; MESSENGER RNA; OCCLUDIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; C57BL 6 MOUSE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; DUODENUM; GENE EXPRESSION; KUPFFER CELL; LIPID PEROXIDATION; LIPOGENESIS; LIVER PROTECTION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BILE ACIDS AND SALTS; DIETARY SUCROSE; DUODENUM; ENDOTOXINS; FATTY LIVER; FRUCTOSE; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650069937     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M007179     Document Type: Article

References (50)

1. Clark, J. M. 2006. The epidemiology of nonalcoholic fatty liver disease in adults. J. Clin. Gastroenterol. 40 (Suppl. 1): S5-S10.
2. Yang, S. Q., H. Z. Lin, A. K. Mandal, J. Huang, and A. M. Diehl. 2001. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology. 34: 694-706.
3. Adams, L. A., J. F. Lymp, S. J. St, S. O. Sanderson, K. D. Lindor, A. Feldstein, and P. Angulo. 2005. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 129: 113-121. (Pubitemid 41002048)
4. Ouyang, X., P. Cirillo, Y. Sautin, S. McCall, J. L. Bruchette, A. M. Diehl, R. J. Johnson, and M. F. Abdelmalek. 2008. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48: 993-999.
5. Ackerman, Z., M. Oron-Herman, M. Grozovski, T. Rosenthal, O. Pappo, G. Link, and B. A. Sela. 2005. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension. 45: 1012-1018.
6. Armutcu, F., O. Coskun, A. Gurel, M. Kanter, M. Can, F. Ucar, and M. Unalacak. 2005. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin. Biochem. 38: 540-547.
7. Bergheim, I., S. Weber, M. Vos, S. Kramer, V. Volynets, S. Kaserouni, C. J. McClain, and S. C. Bischoff. 2008. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48: 983-992.
8. Jurgens, H., W. Haass, T. R. Castaneda, A. Schurmann, C. Koebnick, F. Dombrowski, B. Otto, A. R. Nawrocki, P. E. Scherer, J. Spranger, et al. 2005. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes. Res. 13: 1146-1156.
9. Elliott, S. S., N. L. Keim, J. S. Stern, K. Teff, and P. J. Havel. 2002. Fructose, weight gain, and the insulin resistance syndrome. 176. Am. J. Clin. Nutr. 76: 911-922.
10. Spruss, A., G. Kanuri, S. Wagnerberger, S. Haub, S. C. Bischoff, and I. Bergheim. 2009. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology. 50: 1094-1104.
11. Haub, S., G. Kanuri, V. Volynets, T. Brune, S. C. Bischoff, and I. Bergheim. 2010. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G335-G344.
12. Kanuri, G., A. Spruss, S. Haub, S. Wagneberger, S. C. Bischoff, and I. Bergheim. Role of TNF alpha in the onset of fructose-induced non-alcoholic fatty liver disease. J. Nutr. Biochem. Epub ahead of print. August 27, 2010.
13. Makishima, M., A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan. 1999. Identification of a nuclear receptor for bile acids. Science. 284: 1362-1365.
14. Parks, D. J., S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, et al. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science. 284: 1365-1368.
15. Wang, L., J. Huang, P. Saha, R. N. Kulkarni, M. Hu, Y. Kim, K. Park, L. Chan, A. S. Rajan, I. Lee, et al. 2006. Orphan receptor small heterodimer partner is an important mediator of glucose homeostasis. Mol. Endocrinol. 20: 2671-2681.
16. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell. 89: 331-340.
17. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb. Symp. Quant. Biol. 67: 491-498.
18. Watanabe, M., S. M. Houten, L. Wang, A. Moschetta, D. J. Mangelsdorf, R. A. Heyman, D. D. Moore, and J. Auwerx. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 113: 1408-1418.
19. Watanabe, M., S. M. Houten, C. Mataki, M. A. Christoffolete, B. W. Kim, H. Sato, N. Messaddeq, J. W. Harney, O. Ezaki, T. Kodama, et al. 2006. Bile acids induce energy expenditure by promoting intra cellular thyroid hormone activation. Nature. 439: 484-489. (Pubitemid 43152840)
20. Montet, A. M., L. Oliva, F. Beauge, and J. C. Montet. 2002. Bile salts modulate chronic ethanol-induced hepatotoxicity. 3. Alcohol Alcohol. 37: 25-29.
21. Amann, R. I., B. J. Binder, R. J. Olson, S. W. Chisholm, R. Devereux, and D. A. Stahl. 1990. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl. Environ. Microbiol. 56: 1919-1925.
22. Thuy, S., R. Ladurner, V. Volynets, S. Wagner, S. Strahl, A. Konigsrainer, K. P. Maier, S. C. Bischoff, and I. Bergheim. 2008. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J. Nutr. 138: 1452-1455.
23. Sha, H., Y. He, H. Chen, C. Wang, A. Zenno, H. Shi, X. Yang, X. Zhang, and L. Qi. 2009. The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab. 9: 556-564.
24. Lisbona, F., D. Rojas-Rivera, P. Thielen, S. Zamorano, D. Todd, F. Martinon, A. Glavic, C. Kress, J. H. Lin, P. Walter, et al. 2009. BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. 3. Mol. Cell. 33: 679-691.
25. Kaser, A., A. H. Lee, A. Franke, J. N. Glickman, S. Zeissig, H. Tilg, E. E. Nieuwenhuis, D. E. Higgins, S. Schreiber, L. H. Glimcher, et al. 2008. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. 17. Cell. 134: 743-756.
26. Lorenzo-Zuniga, V., R. Bartoli, R. Planas, A. F. Hofmann, B. Vinado, L. R. Hagey, J. M. Hernandez, J. Mane, M. A. Alvarez, V. Ausina, et al. 2003. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology. 37: 551-557. (Pubitemid 36258776)
27. Cave, M., I. Deaciuc, C. Mendez, Z. Song, S. Joshi-Barve, S. Barve, and C. McClain. 2007. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. 163. J. Nutr. Biochem. 18: 184-195.
28. Le, K. A., and M. Bortolotti. 2008. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. 164. Curr. Opin. Clin. Nutr. Metab. Care. 11: 477-482.
29. Assy, N., G. Nasser, I. Kamayse, W. Nseir, Z. Beniashvili, A. Djibre, and M. Grosovski. 2008. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. 177. Can. J. Gastroenterol. 22: 811-816.
30. Spruss, A., and I. Bergheim. 2009. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J. Nutr. Biochem. 20: 657-662.
31. Leikin-Frenkel, A., I. Goldiner, D. Leikin-Gobbi, R. Rosenberg, H. Bonen, A. Litvak, J. Bernheim, F. M. Konikoff, and T. Gilat. 2008. Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents. 3. Eur. J. Gastroenterol. Hepatol. 20: 1205-1213.
32. Ueno, Y., H. Francis, S. Glaser, S. DeMorrow, J. Venter, A. Benedetti, G. Fava, M. Marzioni, and G. Alpini. 2007. Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 22. Exp. Biol. Med. (Maywood). 232: 942-949.
33. Lam, I. P., L. T. Lee, H. S. Choi, G. Alpini, and B. K. Chow. 2009. Bile acids inhibit duodenal secretin expression via orphan nuclear receptor small heterodimer partner (SHP). 2. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G90-G97.
34. Parlesak, A., S. Schaeckeler, L. Moser, and C. Bode. 2007. Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production. Crit. Care Med. 35: 2367-2374.
35. Zollner, G., M. Wagner, T. Moustafa, P. Fickert, D. Silbert, J. Gumhold, A. Fuchsbichler, E. Halilbasic, H. Denk, H. U. Marschall, et al. 2006. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. 29. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G923-G932.
36. Sommerfeld, A., R. Reinehr, and D. Haussinger. 2009. Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis. 3. J. Biol. Chem. 284: 22173-22183.
37. Fiorucci, S., E. Antonelli, G. Rizzo, B. Renga, A. Mencarelli, L. Riccardi, S. Orlandi, R. Pellicciari, and A. Morelli. 2004. The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology. 127: 1497-1512. (Pubitemid 39457775)
38. Fang, Y., S. I. Han, C. Mitchell, S. Gupta, E. Studer, S. Grant, P. B. Hylemon, and P. Dent. 2004. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology. 40: 961-971.
39. Kobak, G. E., R. Dahl, M. W. Devereaux, E. Gumpricht, M. Traber, R. B. Doctor, and R. J. Sokol. 2005. Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis. 52. J. Lab. Clin. Med. 145: 247-262.
40. Yerushalmi, B., R. Dahl, M. W. Devereaux, E. Gumpricht, and R. J. Sokol. 2001. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology. 33: 616-626.
41. Yki-Jarvinen, H. 2005. Fat in the liver and insulin resistance. Ann. Med. 37: 347-356.
42. Araki, Y., A. Andoh, A. Sasaki, M. Shimada, S. Bamba, S. Fujino, and Y. Fujiyama. 2002. Dietary bile acids inhibit potentially elemental diet-induced small intestinal atrophy in rats. Int. J. Mol. Med. 10: 623-626.
43. McKim, S. E., E. Gabele, F. Isayama, J. C. Lambert, L. M. Tucker, M. D. Wheeler, H. D. Connor, R. P. Mason, M. A. Doll, D. W. Hein, et al. 2003. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. 443. Gastroenterology. 125: 1834-1844.
44. Coeffier, M., R. Gloro, N. Boukhettala, M. Aziz, S. Lecleire, N. Vandaele, M. Antonietti, G. Savoye, C. Bole-Feysot, P. Dechelotte, et al. 2010. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. 2. Am. J. Gastroenterol. 105: 1181-1188.
45. Dalton, J. E., S. M. Cruickshank, C. E. Egan, R. Mears, D. J. Newton, E. M. Andrew, B. Lawrence, G. Howell, K. J. Else, M. J. Gubbels, et al. 2006. Intraepithelial gammadelta+ lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection. Gastroenterology. 131: 818-829.
46. Lauer, M. E., S. C. Erzurum, D. Mukhopadhyay, A. Vasanji, J. Drazba, A. Wang, C. Fulop, and V. C. Hascall. 2008. Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in response to endoplasmic reticulum stress. 3. J. Biol. Chem. 283: 26283-26296.
47. Xie, Q., V. I. Khaoustov, C. C. Chung, J. Sohn, B. Krishnan, D. E. Lewis, and B. Yoffe. 2002. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 36: 592-601.
48. Cahill, C. J. 1983. Prevention of postoperative renal failure in patients with obstructive jaundice-the role of bile salts. 29. Br. J. Surg. 70: 590-595.
49. Sheen-Chen, S. M., P. Chau, and H. W. Harris. 1998. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J. Surg. Res. 80: 205-209.
50. Pumbwe, L., C. A. Skilbeck, V. Nakano, M. J. Avila-Campos, R. M. Piazza, and H. M. Wexler. 2007. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. 7. Microb. Pathog. 43: 78-87.